Companies and Market

share

The global ‘smart pill’ market is expected to be worth $3bn by the year 2025, according to new...

share

The group says money saved from calling time on routine prescriptions for minor, short-term conditions, could be streamed...

share

Furthermore, the company will be able to formulate and manufacture new dosage forms. The expansion includes the addition...

share

Under the deal, Horizon will develop and provide Reference Standard* material expressing neurotrophic tropomyosin receptor kinase (NTRK) fusion...

share

Ahmedabad-based Eris Lifesciences' acquisition of the India brand business of Bengaluru-based Strides Shasun has been in the news. ...

share

Ontruzant is a biosimilar referencing Herceptin (trastuzumab) that can be used to treat patients with early breast cancer,...

share

Fortis Healthcare board has approved the proposed acquisition of entire portfolio of Singapore-listed RHT Health Trust (RHT) for...

share

Biocon's contract research arm Syngene International has expanded its ongoing drug discovery and development with US-based Bristol-Myers Squibb...